Dr. Stephen J. Schuster has been named the inaugural Robert and Margarita
Louis-Dreyfus Associate Professor in Chronic Lymphocytic Leukemia (CLL)
Clinical Care and Research. Dr. Schuster is Director of the Lymphoma Program at the Abramson Cancer Center of the University of Pennsylvania School of Medicine.
"Endowed professorships enable faculty to devote more time to research and patient care, and less to the quest for grant funding. Our first Louis-Dreyfuss Professor certainly fulfills the criterion for outstanding. Dr. Schuster's groundbreaking use of biologic therapies, such as immunotherapy vaccines, offers great promise and has earned him worldwide recognition," said Dr. Arthur H. Rubenstein, Executive Vice President of the University of Pennsylvania for the Health System and Dean of the School of Medicine.
After graduation Jefferson Medical College in 1981, Dr. Schuster completed a residency in Internal Medicine at Pennsylvania Hospital in Philadelphia. He then completed clinical and research fellowships at the Cardeza Foundation for Hematologic Research at Jefferson Medical College, where he joined the faculty in 1989, and conducted laboratory studies related to the cellular and molecular biology of erythropoietin and translational clinical research in hematology and hematologic malignancy. While at Jefferson, he also served as Director of the Hematology/Oncology Fellowship Program, and as the Director for Clinical Programs for the Division of Hematology. In 1998, he joined the Bone Marrow Transplantation and Hematologic Malignancy Program at the University of Pennsylvania. Since that time, his work has focused on the development and application of new therapies for lymphomas, including radioimmunotherapy, patient specific tumor derived vaccines, monoclonal antibody therapy, and immunotherapy with autologous co-stimulated T-cells. Dr. Schuster has received numerous awards and honors for outstanding teaching and research, has been published in multiple scientific journals and magazines, and is world renowned for this revolutionary research advances in leukemia and lymphoma.
This chair was named after Margarita and the late Robert Louis-Dreyfuss, who gratefully supported this effort.